| Deep learning based tissue analysis predicts outcome in colorectal cancer D Bychkov, N Linder, R Turkki, S Nordling, PE Kovanen, C Verrill, ... Scientific reports 8 (1), 3395, 2018 | 602 | 2018 |
| Phase I study with ONCOS-102 for the treatment of solid tumors–an evaluation of clinical response and exploratory analyses of immune markers T Ranki, S Pesonen, A Hemminki, K Partanen, K Kairemo, T Alanko, ... Journal for immunotherapy of cancer 4, 1-18, 2016 | 193 | 2016 |
| Identification of tumor epithelium and stroma in tissue microarrays using texture analysis N Linder, J Konsti, R Turkki, E Rahtu, M Lundin, S Nordling, C Haglund, ... Diagnostic pathology 7, 1-11, 2012 | 186 | 2012 |
| Cellular expression of xanthine oxidoreductase protein in normal human tissues. N Linder, J Rapola, KO Raivio Laboratory investigation; a journal of technical methods and pathology 79 (8 …, 1999 | 176 | 1999 |
| Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein. A Sarnesto, N Linder, KO Raivio Laboratory investigation; a journal of technical methods and pathology 74 (1 …, 1996 | 153 | 1996 |
| A Malaria Diagnostic Tool Based on Computer Vision Screening and Visualization of Plasmodium falciparum Candidate Areas in Digitized Blood Smears N Linder, R Turkki, M Walliander, A Mårtensson, V Diwan, E Rahtu, ... PloS one 9 (8), e104855, 2014 | 135 | 2014 |
| Antibody-supervised deep learning for quantification of tumor-infiltrating immune cells in hematoxylin and eosin stained breast cancer samples R Turkki, N Linder, PE Kovanen, T Pellinen, J Lundin Journal of pathology informatics 7 (1), 38, 2016 | 119 | 2016 |
| Breast cancer outcome prediction with tumour tissue images and machine learning R Turkki, D Byckhov, M Lundin, J Isola, S Nordling, PE Kovanen, C Verrill, ... Breast cancer research and treatment 177, 41-52, 2019 | 105 | 2019 |
| Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer N Linder, J Lundin, J Isola, M Lundin, KO Raivio, H Joensuu Clinical cancer research 11 (12), 4372-4381, 2005 | 96 | 2005 |
| Point-of-care mobile digital microscopy and deep learning for the detection of soil-transmitted helminths and Schistosoma haematobium O Holmström, N Linder, B Ngasala, A Mårtensson, E Linder, M Lundin, ... Global health action 10 (sup3), 1337325, 2017 | 90 | 2017 |
| Long-term prognosis of breast cancer detected by mammography screening or other methods T Lehtimäki, M Lundin, N Linder, H Sihto, K Holli, ... Breast Cancer Research 13, 1-11, 2011 | 83 | 2011 |
| Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy O Hemminki, S Parviainen, J Juhila, R Turkki, N Linder, J Lundin, ... Oncotarget 6 (6), 4467, 2015 | 79 | 2015 |
| Circulating xanthine oxidase and neutrophil activation during human liver transplantation EJ Pesonen, N Linder, KO Raivio, A Sarnesto, R Lapatto, K Höckerstedt, ... Gastroenterology 114 (5), 1009-1015, 1998 | 74 | 1998 |
| Expression and prognostic value of transcription factor PROX1 in colorectal cancer M Skog, P Bono, M Lundin, J Lundin, J Louhimo, N Linder, TV Petrova, ... British journal of cancer 105 (9), 1346-1351, 2011 | 68 | 2011 |
| Point-of-care digital cytology with artificial intelligence for cervical cancer screening in a resource-limited setting O Holmström, N Linder, H Kaingu, N Mbuuko, J Mbete, F Kinyua, ... JAMA network open 4 (3), e211740-e211740, 2021 | 66 | 2021 |
| Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours N Linder, JC Taylor, R Colling, R Pell, E Alveyn, J Joseph, A Protheroe, ... Journal of clinical pathology 72 (2), 157-164, 2019 | 66 | 2019 |
| Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma N Linder, R Bützow, H Lassus, M Lundin, J Lundin Gynecologic oncology 124 (2), 311-318, 2012 | 66 | 2012 |
| Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at … L Vassilev, T Ranki, T Joensuu, E Jäger, J Karbach, C Wahle, K Partanen, ... Oncoimmunology 4 (7), e1017702, 2015 | 57 | 2015 |
| Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes … T Ranki, T Joensuu, E Jäger, J Karbach, C Wahle, K Kairemo, T Alanko, ... Oncoimmunology 3 (10), e958937, 2014 | 56 | 2014 |
| Xanthine oxidoreductase–Clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells N Linder, E Martelin, M Lundin, J Louhimo, S Nordling, C Haglund, ... European Journal of Cancer 45 (4), 648-655, 2009 | 56 | 2009 |
